ADAM17 and neoplasm: To determine the efficacy of the novel ADAM17-directed inhibitory antibody MEDI3622 in combination with IR in a more advanced tumor model, stably transduced firefly luciferase–expressing lung adenocarcinoma cells (A549-Luc) were tail-vein injected into mice to form orthotopic lung tumor nodules.